Search

Your search keyword '"Tabarzad, Maryam"' showing total 142 results
Start Over Author "Tabarzad, Maryam" Publication Year Range Last 10 years
142 results on '"Tabarzad, Maryam"'

4. List of contributors

Author

Agwamba, Ernest C., primary, Ahadian, Samad, additional, Ahmadi, Fatemeh Maghsood, additional, Ahmadian, Roohollah, additional, Akbari, Babak, additional, Akhtari, Negin, additional, Alarcin, Emine, additional, Alem, Halima, additional, Ancira-Cortez, Alejandra, additional, Aref, Amir Reza, additional, Avci-Adali, Meltem, additional, Ayran, Musa, additional, Azarian, Maryam, additional, Bal-Öztürk, Ayça, additional, Barabadi, Hamed, additional, Barati, Maedeh, additional, Bardouni, Mohammad Mahdi, additional, Barzegar, Sajjad, additional, Bilakaya, Besa, additional, Bozlar, Michael, additional, Bozorgchami, Negar, additional, Camlik, Gamze, additional, Cekuc, Mehmet Sertac, additional, Chakafana, Graham, additional, Chakraborty, Gulmi, additional, Chhikara, Nidhi, additional, Cruz-Nova, Pedro, additional, Davari-Kia, Kamyar, additional, De, Ranjit, additional, Degim, Ismail Tuncer, additional, Degim, Zelihagul, additional, Eivazzadeh-Keihan, Reza, additional, Ezati, Negin, additional, Farahani, Ehsan Ortegoli, additional, Farani, Marzieh Ramezani, additional, Fateh, Sahand Tehrani, additional, Fateh, Sepand Tehrani, additional, Fatehi, Dorin, additional, Ghorbani-Bidkorpeh, Fatemeh, additional, Gibbens-Bandala, Brenda, additional, Goshtasbi, Nazanin, additional, Gunduz, Oguzhan, additional, Haeri, Azadeh, additional, Hakimi, Fatemeh, additional, Hamidi, Mehrdad, additional, Hashemi, Atieh, additional, Hassan, Moustapha, additional, Hojjati, Saba, additional, Hosseinabadi, Tahereh, additional, Hosseinpour-Moghadam, Reza, additional, Huh, Yun Suk, additional, Imani, Mahsa, additional, Ipek, Tuba Canak, additional, Jabbari, Farzaneh, additional, Jahani, Reza, additional, Jounaki, Kamyar, additional, Kakavand, Melika, additional, Karami, Kimiya, additional, Karslı, Seher, additional, Katerere, David R., additional, Kaushik, Ajeet, additional, Khajeamiri, Yasaman, additional, Khan, Sofia, additional, Khoramipour, Mahsa, additional, Khoskam, Maryam, additional, Koyuncuoglu, Rumeysa, additional, Kumar, Anuj, additional, Kumar, Govindarajan V., additional, Kumar, Krishan, additional, Kumari, Sonika, additional, Lalebeigi, Farnaz, additional, Lim, Vuanghao, additional, Lotfi, Malihe, additional, Lotfi, Mohammad Javad, additional, Mahata, Manoj Kumar, additional, Makwikwi, Tendai, additional, Maleki, Ali, additional, Maleki, Aziz, additional, Maleksabet, Hanieh, additional, Manicum, Amanda-Lee E., additional, Masoumi, Niloofar, additional, Mehryab, Fatemeh, additional, Meléndez-Alafort, Laura, additional, Merati, Faezeh, additional, Mirshafiyan, Mahshad, additional, Moammeri, Ali, additional, Mohit, Elham, additional, Moradi, Ashkan, additional, Mortazavi, Seyed Alireza, additional, Mortazavi, Seyedeh Maryam, additional, Mosayebnia, Mona, additional, Mostafavi, Ebrahim, additional, Movahed, Mahsa Azami, additional, Naderi, Nooshin, additional, Naei, Vahid Yaghoubi, additional, Namazifard, Saina, additional, Nasiri, Azadeh, additional, Nasri, Negar, additional, Nazari, Hojjatollah, additional, Nejati, Omid, additional, Noqani, Hesam, additional, Ocampo-García, Blanca, additional, Ozarici, Huseyin Berkay, additional, Özcan-Bülbül, Ece, additional, Preetam, Subham, additional, Rad, Dorsa Morshedi, additional, Ramazani, Ali, additional, Rath, Rajeswari, additional, Reeves, Sheena M., additional, Rezaei, Niloufar, additional, Rostami, Sanaz, additional, Saadatidizaji, Zahra, additional, Sabzini, Mahdi, additional, Sadat, Zahra, additional, Sadighian, Somayeh, additional, Sadri, Bahareh, additional, Sahrayi, Hamidreza, additional, Saleemi, Mansab Ali, additional, Salehi-Najafabadi, Amir, additional, Samadi, Amirmasoud, additional, Sanyal, Rupa, additional, Sarrami Foroushani, Elnaz, additional, Seyedhamzeh, Mohammad, additional, Shamsabadipour, Amin, additional, Sharma, Ajay, additional, Sharma, Anil Kumar, additional, Sharma, Anirudh, additional, Sharma, Saurabh, additional, Sharma, Varruchi, additional, Singh, Jasdeep, additional, Song, Yo Han, additional, Soni, Savita, additional, Sood, Ankur, additional, Subudhi, P. Debishree, additional, Tabarzad, Maryam, additional, Tabatabaei, Mahsa Seyed, additional, Taghizadeh, Fatemeh, additional, Tayebi, Lobat, additional, Ulag, Songul, additional, Uyar, Perihan, additional, Vosough, Massoud, additional, Warkiani, Majid Ebrahimi, additional, Yavari, Maryam, additional, Yaşayan, Gökçen, additional, Yildiz, Irem, additional, Zare, Iman, additional, Zare, Mohammad Reza, additional, Zarepour, Atefeh, additional, Zarkesh, Ibrahim, additional, and Zarrabi, Ali, additional

Published
2024
Full Text
View/download PDF

11. Contributors

Author

Abolmaali, Samira S., primary, Ahadian, Samad, additional, Ahmadi, Mahnaz, additional, Akhlaghi, Sarah, additional, Alimardani, Vahid, additional, Aminudin, Nurul I., additional, Asadian, Elham, additional, Ashammakhi, Nureddin, additional, Ashkarran, Ali A., additional, Asmelash, Tsehaye, additional, Balhaddad, Abdulrahman A., additional, Barabadi, Hamed, additional, Bardouni, Mohammad M., additional, Bayat, Fereshteh, additional, Borhan, Ali, additional, Bălăceanu, Beatrice, additional, Cholula-Díaz, Jorge L., additional, Collares, Fabrício M., additional, Danial, Wan H., additional, Darbasizadeh, Behzad, additional, Derakhshi, Maryam, additional, Esquivel-López, Ivana Gabriela, additional, Farahavar, Ghazal, additional, Feyzi-barnaji, Bahareh, additional, Gandomkarzadeh, Marzieh, additional, Garcia, Isadora M., additional, Gayathri, M., additional, Gebrecherkos, Teklay, additional, Ghorbani-Bidkorbeh, Fatemeh, additional, Gorji-bahri, Gilar, additional, Gurău, Cristian-Dorin, additional, Haeri, Azadeh, additional, Hamidi, Sarvin, additional, Hamzah, Nurasyikin, additional, Hashemi, Atieh, additional, Holban, Alina-Maria, additional, Ion, Ana, additional, Ismail, Mohamad W., additional, Kanada, Masamitsu, additional, Karimi, Maede, additional, Kayalan, Irmak C., additional, Khezri, Fatemeh, additional, Lazăr, Veronica, additional, Lotfi, Mohammad J., additional, Mahboubi, Arash, additional, Martínez-Sanmiguel, Juan J., additional, Masoudifar, Reyhane, additional, Medina-Cruz, David, additional, Mehryab, Fatemeh, additional, Melo, Mary Anne S., additional, Mihai, Mara Mădălina, additional, Moghimi, Hamid Reza, additional, Mohit, Elham, additional, Mokeem, Lamia, additional, Mortazavi, Seyedeh Maryam, additional, Mosayebnia, Mona, additional, Mostafavi, Ebrahim, additional, Movahed, Mahsa A., additional, Murugan, Arumugam, additional, Muzaddadi, Ijaz U., additional, Naderi, Nima, additional, Najafi, Haniyeh, additional, Nazari, Maryam, additional, Pishva, Parsa, additional, Pon Janani, S., additional, Pouyanfar, Niki, additional, Pérez, Yeremi, additional, Ravikumar, C.R., additional, Rezaee, Elham, additional, Saravanan, Muthupandian, additional, Sefat, Farshid, additional, Sehgal, Rakesh, additional, Sert, Fatma, additional, Shafiee, Mina, additional, Shafiee, Saiful A., additional, Shahbazi, Mohammad-Ali, additional, Sinha, Shweta, additional, Soto-Mendoza, Adrián, additional, Susanti, Deny, additional, Swaminathan, Akila, additional, Tabarzad, Maryam, additional, Taher, Muhammad, additional, Tamaddon, Ali M., additional, Tanideh, Nader, additional, Theijeswini, R.C., additional, Thillai Arasu, P., additional, Truong, Linh B., additional, Walker, Jordan C., additional, Yadav, Nagendra N., additional, Yadav, Hardeo S., additional, and Yüce, Meral, additional

Published
2022
Full Text
View/download PDF

16. Contributors

Author

Ahmed, Farhan J., primary, Akbari, Somaye, additional, Alibolandi, Mona, additional, Amreddy, Narsireddy, additional, Arbeloa, Ernesto M., additional, Bandaru, Ravi, additional, Bertolotti, Sonia G., additional, Carvalho, Mariana R., additional, Choudhury, Hira, additional, Dandela, Rambabu, additional, Denora, Nunzio, additional, Dewangan, Rikeshwar Prasad, additional, Dolatabadi, Jafar Ezzati Nazhad, additional, Espinar Buitrago, M. de la Sierra, additional, Ferreira, Elizabeth Igne, additional, Gawande, Vandana, additional, Ghorbani-Bidkorbeh, Fatemeh, additional, Giarolla, Jeanine, additional, Golshan, Marzieh, additional, González-Méndez, Israel, additional, Gorain, Bapi, additional, Grabchev, Ivo, additional, Hamblin, Michael R., additional, Hosseinabadi, Tahereh, additional, Iacobazzi, Rosa Maria, additional, Jabar, A., additional, Jain, Gaurav K., additional, Jain, Keerti, additional, Jain, Narendra Kumar, additional, Kamble, Omkar, additional, Kesharwani, Prashant, additional, Kheiriabad, Shiva, additional, Khot, Shubham V., additional, Kokare, Chandrakant R., additional, Kumbhar, Santosh Ashok, additional, Mahmoudi, Asma, additional, Malaekeh-Nikouei, Bizhan, additional, Masrour, R., additional, Militello, M. Paula, additional, Molugulu, Nagashekhara, additional, Muñoz Fernández, M. Ángeles, additional, Munshi, Anupama, additional, Oliveira, Isabel M., additional, Oliveira, Joaquim M., additional, Pandey, Manisha, additional, Previtali, Carlos M., additional, Ramesh, Rajagopal, additional, Ramezani, Mohammad, additional, Rawat, Pinki, additional, Razmshoar, Pouyan, additional, Reis, Rui L., additional, Rekha, Smruti, additional, Rivera, Ernesto, additional, Ruiu, Andrea, additional, Sadi, Kiana Sherkat, additional, Sahdane, T., additional, Salami-Kalajahi, Mehdi, additional, Samal, Sangram K., additional, Sanches, Luccas Missfeldt, additional, Sanket, A. Swaroop, additional, Santos, Soraya da Silva, additional, Sehrawat, Shivani, additional, Shahriari, Mahsa, additional, Shakoorjavan, Sima, additional, Silva, João Vitor, additional, Singh, Gunjan, additional, Singh, Sima, additional, Singh, Vijender, additional, Sisinthy, Sreenivas Patro, additional, Sorroza-Martínez, Kendra, additional, Staneva, Desislava, additional, and Tabarzad, Maryam, additional

Published
2021
Full Text
View/download PDF

26. Synthesis and evaluation of Escitalopram-loaded niosomes on colon cancer cell lines.

Author

Yeganeh, Faten Eshrati, Tabarzad, Maryam, Khazraei, Hajar, and Bourbour, Mahsa

Subjects
*COLON cancer, *CANCER cells, *CELL lines, *SEROTONIN uptake inhibitors, *CYTOTOXINS
Abstract

Introduction: It has been approved that selective serotonin reuptake inhibitors (SSRIs) may exhibit anti-proliferative or cytotoxic effects on several types of cancers. The aim of the present study was to evaluate the cytotoxic effects of a newly formulated niosome of Escitalopram oxalate on a colorectal cancer cell line. Methods: The niosomes were prepared using a thin layer hydration method, resulting in particles with a size range between 150 – 450 nm and spherical morphology. Moreover, its permeability release showed 25% in 4 hours. The cytotoxicity evaluation was performed using a quantitative colorimetric MTT assay. Results: The cell viability of colon cancer cells after treatment with niosomes and pure escitalopram reduced to 28.3 ± 0.83 % and 24.07 ± 0.56%, respectively. However, the cytotoxicity assay of escitalopram-loaded niosomes suggested that the anti-proliferative effect of the niosomal formulation of escitalopram was dose and incubation time-dependent. Conclusion: These results confirm the potential of the anti-proliferative activity of escitalopram-loaded niosomes. Further application to an in vivo model is needed to study various pharmacokinetic and pharmacodynamics parameters to establish its complete therapeutic potential. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

31. Insight into the Infectious Diseases Associated with Celiac Disease: A Guild to Novel Approaches for Diagnosis and Treatment.

Author

Foroughinia, Farzaneh, Ansari, Ramin, and Tabarzad, Maryam

Subjects
BACTERIAL disease risk factors, CELIAC disease complications, COMMUNICABLE disease treatment, COMMUNICABLE disease diagnosis, HEPATITIS B, GIARDIASIS, COMMUNICABLE diseases, RETROVIRUS diseases, CAMPYLOBACTER infections, RISK assessment, CELIAC disease, VIRUS diseases, MYCOSES, PARASITIC diseases, INFLUENZA, PROTOZOAN diseases, LITERATURE reviews, HELICOBACTER diseases, ANTIBIOTICS, DISEASE risk factors
Abstract

Background: Celiac disease (CD) is one of the most common and chronic immune-mediated disorders of the gastrointestinal tract that affects the small intestine. Genetic factors, including human leukocyte antigen (HLA), and non-HLA genes are major risk factors in CD pathology. Moreover, environmental factors such as infections may affect CD incidence. Materials and Methods: The goal of the present study is to investigate the association between CD and viral, bacterial, fungal, and parasitic infections. Databases including Scopus, PubMed, Google Scholar, and Web of Science were searched for relevant literature until 2022. Results: Several infections have been reported to be associated with CD including reovirus, rotavirus, hepatitis B virus, influenza virus, helicobacter pylori, campylobacter jejuni, giardia lamblia, toxoplasma gondii, candida albicans, etc. Conclusion: Moreover, antibiotic administration might be a risk factor for further CD development. On the other hand, there are reports regarding the susceptibility of patients with CD to some infections, as well as protective infections against CD. Consequently, more studies are required to explain the two-sided relations between CD and infectious diseases. [ABSTRACT FROM AUTHOR]

Published
2023

34. The Epigenetic Regulation of Blinatumomab Gene Expression: Tumor Cell-dependent T cell Response against Lymphoma Cells and Cytotoxic Activity

Author

Naddafi, Fatemeh, Mahboudi, Fereidoun, Tabarzad, Maryam, Aliabadi Farahani, Zahra, Hosein. Shirazi, Farshad, and Davami, Fatemeh

Subjects
BiTE, Blinatumomab, T-cell activation, Original Article, refractory acute lymphoid leukemia, therapeutic anti- CD19 mAb
Abstract

Conventional treatment for cancer such as surgical resection and chemotherapy can cause damage in cases with advanced cancers. Moreover, the identification of tumor-specific targets has great importance in T-cell therapies. For decades, T cell activity has been stimulated to improve anti-tumor activity. Bispecific antibodies have attracted strong interest from pharmaceutical companies, for their diagnostic and therapeutic use. Blinatumomab is a first-in-class bispecific T engager antibody for the treatment of relapsed or refractory precursor B- cell acute lymphoblastic leukemia. But, it can benefit several cases with CD19+ malignancies in the future. PhiC31 integrase-based vectors could selectively integrate therapeutic transgenes into pseudo-attP sites in CHO genome. In this study, production of Blinatumomab in CHO cells using this type of vectors was investigated. We evaluated the effects of histone deacetylases (HDACs) inhibitors such as sodium butyrate and valproic acid, on specific productivity and cell viability of antibody expressing cells. Although sodium butyrate increased specific productivity about 1.7-fold and valproic acid about 1.4-fold, valproic acid was found more efficient because of its less cytotoxic effect on cell growth. We examined the efficacy of expressed Blinatumomab at various effector to target (E/T) ratios. A dose-response analyses of calcein-acetoxymethyl release assay illustrated that the effective dose of expressed mAb required for antibody mediated cytotoxicity was 100 ng/ml and the expressed mAb was more effective at E/T ratios of 10:1 and 5:1. Results of this study indicated that the expressed blinatumomab can be useful for enhancing the cytotoxicity of CD3+ T-cells against CD19 + target cells in vitro.

Published
2019

37. Can Aptameric Ligands Specific to Plasma Coagulation Factor VII Bind the Recombinant Form with High Affinity: Affinity Measurement by Fluorescence Method

Author

Tabarzad, Maryam, Jafari, Marzieh, and Nafissi-varcheh, Nastaran

Subjects
Affinity, Aptamer, Short Communication, Factor VIIa, Fluorescence
Abstract

Background: Among diverse protein purification systems, affinity chromatography is the most attractive one in the purification process of coagulation factors. Coagulation factor VII is a plasma serine protease that has a significant role in natural human hemostasis and its recombinant form such as AryoSeven™, has been applied in clinical treatment of bleeding disorders. Immunoaffinity chromatography is the purification method of choice that is currently applied in the development of coagulation factor VIIa products. Aptamers as nucleic acid based affinity ligands are more promising than monoclonal antibodies. In addition, DNA aptamers are more acceptable than RNA ones in this regard. Methods: In this study, two of the aptameric DNA oligonucleotides that showed acceptable affinities for purification of coagulation factor VIIa from plasma, were selected to evaluate their affinity against Aryoseven. A serial dilution of fluorescence labeled aptamers was incubated against the concentration of 1 nM from Aryoseven. Then, a fluorescence index was calculated according to the fluorescence intensity data measured from test and control samples. The dissociation constant of aptamers was calculated according to the fluorescence index using Prism5 software. Results: Results showed that the binding affinity of the 44 nucleotide aptamer was more than 81 nucleotide aptamer sequence. As a result, this aptamer could be optimized in order to develop aptamer based affinity chromatography process for this form of recombinant coagulation factor VIIa. Discussion: Aptamers with shorter length of sequence could show higher affinity in target binding, as they could adapt more easily to suitable conformation according to target interaction. However, it should be considered that the selectivity of affinity ligands is also important for target purification and analytical applications.

Published
2017

46. Meet Our Co-Editor

Author

Cheorl-Ho Kim, Nader Shokoufi Atefeh Abbasi-Ahd, Javad Ranjbari, Ahad Mokhtarzadeh, Abbas Alibakhshi, Maryam Tabarzad , Maryam Hejazi, Hongbin Sun, Kazem Kargosha, Ting Liu, Mingchen Fu, Oscar Arias-Carrion, Ti-Fei Yuan, Gokhan Zengin, and Mohammad Ramezani

Subjects
Pharmaceutical Science, Biotechnology
Published
2017

Catalog

Books, media, physical & digital resources
See catalog results